Verastem Inc

NASDAQ:VSTM   12:41:46 PM EDT
1.25
+0.01 (+0.81%)
Earnings Announcements

Verastem Oncology Reports Q4 Results

Published: 03/28/2022 11:21 GMT
Verastem Inc (VSTM) - Q4 Adjusted Non-GAAP Loss per Share $0.08.
Q4 Loss per Share $0.09.
Q4 Revenue $500,000.
Q4 Earnings per Share View $-0.09, Revenue View $40000.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.